#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Usher's syndrome Small intestine leiomyosarcoma Univentricular heart CDKL5 deficiency disorder Essential thrombocythaemia Adenoid cystic carcinoma Soft tissue sarcoma Polyneuropathy Myotonic dystrophy Acquired C1 inhibitor deficiency Fragile X syndrome Cholestatic pruritus Bronchiectasis Allogenic stem cell transplantation Systemic scleroderma More trials…

    Learn about Rare Diseases

    KBG syndrome – Basic Information Proteus syndrome – Basic Information Alport’s syndrome – Treatment Familial amyotrophic lateral sclerosis – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) Wolfram syndrome Rosai-Dorfman syndrome – Basic Information Ehlers-Danlos syndrome – Life with Disease Synovial sarcoma – Trials in Disease Synovial sarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Albiglutide Opevesostat Tosilate Fludarabine GOLD SODIUM THIOSULFATE Ucart22 Esflurbiprofen Tianeptine ALPROSTADIL Gr0015 Vincristine Sulfate Ruxolitinib Calcitriol Bosentan Nandrolone Decanoate Sodium Chloride Solution 0.9% Palbociclib ADX-038 Peposertib Gremubamab Trospium Chloride More therapies…

    Learn about Your Condition

    Urinary tract infection Anxiety disorder Myocarditis Round cell liposarcoma Radius fracture Enteritis Meniere's disease Adenosquamous cell lung cancer Nephrotic syndrome Tuberculosis Neuroendocrine tumour Brain abscess Uveal melanoma Muscle spasticity Univentricular heart More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study of mirikizumab and tirzepatide for adults with moderate to severe Crohn’s disease who are overweight or obese

    Recruiting

    3 1
    Investigated Drugs:
    • Mirikizumab
    • Tirzepatide
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Efficacy and Safety of Brenipatide (LY3537031) in Adults with Irritable Bowel Syndrome‑Constipation (IBS‑C) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

    Recruiting

    2 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Investigated Drugs:
    • LY3537031
    Belgium Spain

  • Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Croatia Czechia France Greece Hungary Italy +5

  • A Phase 2a Study Evaluating the Efficacy and Safety of MK-8690 in Adults with Moderately to Severely Active Ulcerative Colitis

    Recruiting

    2 1
    France Germany Greece Italy The Netherlands Poland

  • Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • SPY002
    Austria Belgium Bulgaria Croatia Czechia France +9

  • Modafinil for Severe Fatigue in Patients with Quiescent Inflammatory Bowel Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    Investigated Drugs:
    • Modafinil
    • Placebo
    The Netherlands
1 2 3 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!